🇺🇸 FDA
Pipeline program

Iopofosine I 131 single dose

DCL-16-001

Phase 2 small_molecule active

Quick answer

Iopofosine I 131 single dose for Waldenstrom Macroglobulinemia is a Phase 2 program (small_molecule) at Cellectar Biosciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Cellectar Biosciences
Indication
Waldenstrom Macroglobulinemia
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials